Growth Stories is a podcast about the innovations and trends driving the stock market’s next big winners. IBD multimedia reporter Alexis Garcia interviews analysts, executives, authors and influencers to take investors behind the latest innovations and trends driving growth in leading companies and sectors.
All content for Growth Stories With IBD is the property of Investor's Business Daily and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Growth Stories is a podcast about the innovations and trends driving the stock market’s next big winners. IBD multimedia reporter Alexis Garcia interviews analysts, executives, authors and influencers to take investors behind the latest innovations and trends driving growth in leading companies and sectors.
Novo Nordisk Is Losing Its Lead To Eli Lilly In The Obesity Drug War. Here’s What Went Wrong.
Growth Stories With IBD
19 minutes
2 months ago
Novo Nordisk Is Losing Its Lead To Eli Lilly In The Obesity Drug War. Here’s What Went Wrong.
On this episode of Growth Stories, we take a look at the escalating rivalry between Novo Nordisk and Eli Lilly and how the Danish drugmaker lost its grip on the weight-loss drug market.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Growth Stories With IBD
Growth Stories is a podcast about the innovations and trends driving the stock market’s next big winners. IBD multimedia reporter Alexis Garcia interviews analysts, executives, authors and influencers to take investors behind the latest innovations and trends driving growth in leading companies and sectors.
